324
Views
33
CrossRef citations to date
0
Altmetric
Original Research Paper

Leptospira seropositivity as a risk factor for Mesoamerican Nephropathy

ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, , , , , , & show all
Pages 1-10 | Received 21 Jan 2016, Accepted 08 Dec 2016, Published online: 17 Feb 2017
 

Abstract

Background: Leptospirosis is postulated as a possible cause of Mesoamerican Nephropathy (MeN) in Central American workers.

Objectives: Investigate job-specific Leptospira seroprevalence and its association with kidney disease biomarkers.

Methods: In 282 sugarcane workers, 47 sugarcane applicants and 160 workers in other industries, we measured anti-leptospiral antibodies, serum creatinine, and urinary injury biomarkers, including neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), and N-acetyl-D-glucosaminidase (NAG).

Results: Leptospira seroprevalence differed among job categories and was highest among sugarcane cutters (59%). Seropositive sugarcane workers had higher NGAL concentrations (relative mean: 1.28; 95% CI: 0.94–1.75) compared to those who were seronegative, with similar findings among field and non-field workers.

Conclusions: Leptospira seroprevalence varied by job category. There was some indication that seropositivity was associated with elevated biomarker levels, but results were inconsistent. Additional studies may help establish whether Leptospira infection plays any role in MeN among Central American workers.

Acknowledgments

We thank the workers for their participation in this study. We also thank the Nicaraguan Ministry of Health for contributions to the field investigation and laboratory support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.